US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
US4356170A
(en)
*
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
US4761283A
(en)
*
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
JPS626698A
(ja)
*
|
1985-07-03 |
1987-01-13 |
Hayashibara Biochem Lab Inc |
ガラクチト−ルの測定方法
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US5785973A
(en)
*
|
1988-02-01 |
1998-07-28 |
Praxis Biologics, Inc. |
Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
|
NZ241926A
(en)
|
1988-08-25 |
1993-08-26 |
Liposome Co Inc |
Immunisation dosage form comprising a salt of an organic acid derivative of a sterol and an antigen
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
DE68907045T2
(de)
|
1989-01-17 |
1993-12-02 |
Eniricerche Spa |
Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind.
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
CA2063271A1
(en)
|
1989-07-14 |
1991-01-15 |
Subramonia Pillai |
Cytokine and hormone carriers for conjugate vaccines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
WO1992002817A1
(en)
*
|
1990-08-02 |
1992-02-20 |
Biocarb, Inc. |
Adhesion receptors for pathogenic or opportunistic microorganisms
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
JP3755890B2
(ja)
|
1992-06-25 |
2006-03-15 |
スミスクライン・ビーチャム・バイオロジカルス(ソシエテ・アノニム) |
アジュバント含有ワクチン組成物
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
ZA937034B
(en)
|
1992-09-24 |
1995-06-23 |
Brigham & Womens Hospital |
Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
|
PT667787E
(pt)
*
|
1992-09-24 |
2001-10-31 |
Brigham & Womens Hospital |
Vacinas de conjugado de polissacarido-proteina de estreptococos do grupo b do tipo ii e tipo v
|
EP0812593B8
(en)
|
1993-03-23 |
2010-11-10 |
SmithKline Beecham Biologicals S.A. |
Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
JP4233113B2
(ja)
|
1995-06-07 |
2009-03-04 |
グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム |
多糖類抗原−キャリア蛋白接合体および遊離キャリア蛋白を有してなるワクチン
|
US6284884B1
(en)
*
|
1995-06-07 |
2001-09-04 |
North American Vaccine, Inc. |
Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
EP1005368B1
(en)
|
1997-03-10 |
2009-09-02 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants
|
US6426074B1
(en)
*
|
1997-03-19 |
2002-07-30 |
The Brigham And Women's Hospital Inc. |
Group B Streptococcus vaccine
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
JP2001519817A
(ja)
|
1997-03-26 |
2001-10-23 |
ブリガム アンド ウイメンズ ホスピタル |
糖断片生成法
|
PT970114E
(pt)
*
|
1997-04-18 |
2006-12-29 |
Novartis Ag |
Neoglicoproteínas
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
JP4426091B2
(ja)
|
1997-09-05 |
2010-03-03 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
サポニンを含有する水中油型エマルション
|
CA2305599A1
(en)
*
|
1997-10-03 |
1999-04-15 |
Galenica Pharmaceuticals, Inc. |
Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
|
CA2671261A1
(en)
|
1997-11-06 |
1999-05-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigens
|
AU762606B2
(en)
|
1997-11-21 |
2003-06-26 |
Genset S.A. |
Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
|
KR100735653B1
(ko)
|
1997-11-28 |
2007-07-06 |
세로노 제네틱스 인스티튜트 에스.에이. |
클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
KR100757630B1
(ko)
*
|
1997-12-23 |
2007-09-10 |
박스터 헬쓰케어 에스.에이. |
신규한 추출 및 단리 방법으로 수득되는 세균성 캡슐형 다당류
|
US20010051364A1
(en)
*
|
1997-12-23 |
2001-12-13 |
Francis Michon |
Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
|
ATE446368T1
(de)
|
1998-01-14 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
WO1999036469A1
(en)
*
|
1998-01-16 |
1999-07-22 |
Unilever N.V. |
Polysaccharide conjugate capable of binding cellulose
|
KR100585408B1
(ko)
|
1998-02-12 |
2006-06-01 |
와이어쓰 홀딩스 코포레이션 |
인터루킨-12로 제형된 폐렴구균 및 수막구균 백신
|
US7018637B2
(en)
*
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
US6645503B1
(en)
*
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
KR20010042573A
(ko)
|
1998-04-09 |
2001-05-25 |
장 스테판느 |
애쥬번트 조성물
|
US6573245B1
(en)
*
|
1998-04-28 |
2003-06-03 |
Galenica Pharmaceuticals, Inc. |
Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
|
EP2261355A3
(en)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
JP2004505885A
(ja)
|
1998-08-19 |
2004-02-26 |
ノース アメリカン ワクチン, インコーポレイテッド |
N−アクリロイル化ポリサッカリドを用いて産生されたワクチンとして有用な免疫原性β−プロピオンアミド連結ポリサッカリド−タンパク質結合体
|
JP2004511201A
(ja)
|
1998-10-09 |
2004-04-15 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
AU750587B2
(en)
|
1998-10-16 |
2002-07-25 |
Smithkline Beecham Biologicals (Sa) |
Adjuvant systems and vaccines
|
CA2350775A1
(en)
|
1998-11-12 |
2000-05-18 |
The Regents Of The University Of California |
Chlamydia pneumoniae genome sequence
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
EP1034792A1
(en)
|
1999-03-11 |
2000-09-13 |
Pasteur Merieux Serums Et Vaccins |
Intranasal delivery of pneumococcal polysaccharide vaccines
|
JP4846906B2
(ja)
|
1999-03-19 |
2011-12-28 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
CN1391483A
(zh)
|
1999-09-24 |
2003-01-15 |
史密丝克莱恩比彻姆生物有限公司 |
作为佐剂的聚氧乙烯脱水山梨醇酯和辛苯昔醇组合及其在疫苗中的应用
|
WO2001021152A1
(en)
|
1999-09-24 |
2001-03-29 |
Smithkline Beecham Biologicals S.A. |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
ES2507100T3
(es)
|
2000-01-17 |
2014-10-14 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacuna OMV suplementada contra meningococo
|
CA2396871A1
(en)
|
2000-01-20 |
2001-12-20 |
Ottawa Health Research Institute |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
DE60139690D1
(de)
|
2000-07-03 |
2009-10-08 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
US7892552B2
(en)
*
|
2001-08-08 |
2011-02-22 |
University Of Utah Research Foundation |
Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
|
US7128919B2
(en)
*
|
2000-08-08 |
2006-10-31 |
St. Jude Children's Research Hospital |
Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
|
WO2002026757A2
(en)
|
2000-09-26 |
2002-04-04 |
Hybridon, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
EP2189473A3
(en)
*
|
2000-10-27 |
2010-08-11 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic and proteins from streptococcus groups A & B
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
GB0115176D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
RU2323002C2
(ru)
|
2001-07-26 |
2008-04-27 |
Чирон Срл. |
Вакцины, содержащие алюминиевые адъюванты и гистидин
|
US7534442B2
(en)
*
|
2001-08-21 |
2009-05-19 |
The Brigham And Women's Hospital, Inc. |
Immunogenic compositions comprising covalently bound polysaccharides, antigen, and bacterial toxoid
|
US20030091593A1
(en)
|
2001-09-14 |
2003-05-15 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
US7265085B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
GB0210128D0
(en)
|
2002-05-02 |
2002-06-12 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups A & B
|
US20040096461A1
(en)
*
|
2002-07-30 |
2004-05-20 |
Baxter Healthcare Corporation |
Chimeric multivalent polysaccharide conjugate vaccines
|
EP1597348A4
(en)
|
2002-08-26 |
2010-03-31 |
Novartis Vaccines & Diagnostic |
GENES OF STREPTOCOCCUS PRESERVED OR SPECIFIC
|
EP1551357B1
(en)
*
|
2002-09-13 |
2014-07-16 |
Novartis Vaccines and Diagnostics, Inc. |
Group b streptococcus vaccine
|
CA2511646A1
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
EP1594524B1
(en)
|
2003-01-21 |
2012-08-15 |
Novartis Vaccines and Diagnostics, Inc. |
Use of tryptanthrin compounds for immune potentiation
|
EP2191844B1
(en)
*
|
2003-01-30 |
2014-03-05 |
Novartis AG |
Injectable vaccines against multiple meningococcal serogroups
|
US7438912B2
(en)
*
|
2003-05-07 |
2008-10-21 |
Intercell Ag |
S.agalactiae antigens I + II
|
CA2532369C
(en)
*
|
2003-07-31 |
2016-07-26 |
Chiron Corporation |
Immunogenic compositions for streptococcus pyogenes
|
CN103623405B
(zh)
*
|
2003-08-06 |
2016-06-15 |
美国政府健康及人类服务部 |
多糖-蛋白轭合物疫苗
|
US8048432B2
(en)
*
|
2003-08-06 |
2011-11-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Polysaccharide-protein conjugate vaccines
|
US20060198819A1
(en)
*
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
WO2005072778A2
(en)
*
|
2004-01-29 |
2005-08-11 |
Biosynexus, Inc. |
Use of amino-oxy functional groups in the preparation of vaccines conjugates
|
WO2006050341A2
(en)
*
|
2004-11-01 |
2006-05-11 |
The Brigham And Women's Hospital, Inc. |
Modified streptococcal polysaccharides and uses thereof
|
GB0502096D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
GB0502095D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
EP1937304A2
(en)
*
|
2005-08-24 |
2008-07-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Zwitterionization of capsular saccharides
|
US7700578B2
(en)
*
|
2005-09-21 |
2010-04-20 |
The United States Of America As Represented By The Secretary Of The Navy |
Capsule composition for use as immunogen against Campylobacter jejuni
|
GB0522303D0
(en)
*
|
2005-11-01 |
2005-12-07 |
Chiron Srl |
Culture method
|
JP2009527572A
(ja)
*
|
2006-02-24 |
2009-07-30 |
ノバルティス アーゲー |
免疫原性組成物に使用するための生分解性ポリマーおよびカチオン性多糖を含むミクロ粒子
|
EP2170391B1
(en)
*
|
2007-06-20 |
2017-01-18 |
Pfizer Ireland Pharmaceuticals |
Modified polysaccharides for conjugate vaccines
|
GB0713880D0
(en)
*
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
CN103897045A
(zh)
*
|
2009-01-12 |
2014-07-02 |
诺华股份有限公司 |
抗革兰氏阳性细菌疫苗中的Cna_B结构域
|
GB201101665D0
(en)
*
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|